Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026)
Incannex Healthcare (IXHL) posted Profit After Tax of -$4.4 million for Q1 2026, up 33.28% sequentially from -$6.5 million in Q4 2025, and down 7.27% YoY from -$4.7 million in Q1 2025.
Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026) Analysis & Trends
Incannex Healthcare has reported Profit After Tax for 5 years, with the latest figure at -$4.4 million in Q1 2026.
- Quarterly Profit After Tax fell 7.27% year-over-year to -$4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.7 million (down 126.55% YoY) and the FY2025 annual result came in at -$46.9 million, down 152.94% from the prior year.
- Profit After Tax climbed to -$4.4 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$1.2 million in Q3 2023 and troughed at -$31.4 million in Q2 2025.
- A 5-year average of -$7.0 million and a median of -$5.7 million in 2024 frame the typical range for Profit After Tax.
- The widest YoY moves for Profit After Tax: up 40.8% in 2025, down 412.47% in 2025.
- Over 5 years, Profit After Tax stood at -$2.9 million in 2022, then slumped by 79.61% to -$5.2 million in 2023, then decreased by 12.46% to -$5.9 million in 2024, then dropped by 10.64% to -$6.5 million in 2025, then soared by 33.28% to -$4.4 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$4.4 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | -4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.35 Mn |
| Dec 31, 2025 | -6.52 Mn |
| Sep 30, 2025 | -6.41 Mn |
| Jun 30, 2025 | -31.44 Mn |
| Mar 31, 2025 | -4.06 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -6.14 Mn |
| Mar 31, 2024 | -6.85 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -1.24 Mn |
| Jun 30, 2023 | -7.75 Mn |
| Mar 31, 2023 | -3.77 Mn |
| Dec 31, 2022 | -2.92 Mn |